Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

The Ensign Group Inc (ENSG)

  • Business News
  • Nov. 03, 2025, 11:00 UTC
  • 18
  • 1 comments

The Ensign Group Expands in Utah

Market reaction Comment Full text

The Ensign Group Inc (ENSG)

  • Business News
  • Nov. 03, 2025, 11:00 UTC
  • 19
  • 1 comments

The Ensign Group Adds Operation in Alabama

Market reaction Comment Full text

SOHM, Inc. (SHMN)

  • Business News
  • Nov. 03, 2025, 10:55 UTC
  • 17
  • 1 comments

Lorem Ipsum is simply dummy text

Market reaction Comment Full text

Bristol-Myers Squibb Company (BMY)

  • Business News
  • Nov. 03, 2025, 09:55 UTC
  • 17
  • 1 comments

Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes

Market reaction Comment Full text

Bristol-Myers Squibb Co. (BMYMP)

  • Business News
  • Nov. 03, 2025, 09:55 UTC
  • 18
  • 1 comments

Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes

Market reaction Comment Full text

Cytokinetics Inc (CYTK)

  • Business News
  • Nov. 03, 2025, 08:08 UTC
  • 20
  • 1 comments

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

Lantheus Holdings Inc. (LNTH)

  • Business News
  • Nov. 03, 2025, 08:01 UTC
  • 20
  • 1 comments

Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

Market reaction Comment Full text

Savara Inc. (SVRA)

  • Business News
  • Nov. 03, 2025, 07:56 UTC
  • 17
  • 1 comments

Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SVRA

Market reaction Comment Full text

Savara Inc. (SVRA)

  • Business News
  • Nov. 03, 2025, 07:52 UTC
  • 20
  • 1 comments

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

DexCom Inc (DXCM)

  • Business News
  • Nov. 03, 2025, 07:37 UTC
  • 19
  • 1 comments

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text
  • Previous
  • 922
  • 923
  • 924
  • 925
  • 926
  • Next

Search

News categories

  • Technical Exchange News(11014)
  • Event(2495)
  • SEC News(195076)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(126816)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin